Ten times normal volume and the short count must have increased, perhaps a few covered today, but after hours we are moving higher, and as there is no, and I mean NO tangible bad news about the performance of Ampion, I am buying here.
Took you off ignore to say that you are a known short spreading FUD all the time, so back on ignore just after I say you are really an idiot complete knucklehead, if you were in front of me I'd prolly have to smack you.
Do you know why? If you are long you absolutely know why!
Pima rocks and will revolutionize the way dementia is treated.
This is the year of Acadia, own it or don't, but do not sell this stock short.
I say tradergo, as in go away, your FUD has been noticed, and this is no failure of a trial, but a delay for data review yes, so just go trader just go.
TO ALL LONGS:
The stock currently trades where it did in late July or just a few weeks ago, did you sell then? Why sell now? Yes we are upset about the trial execution. This is not the fault of the company or management however, the fact is--- that Ampion works. The trial dosages were packaged correctly under the watchful eye of the FDA representatives in early January and were to be maintained in the mid sixty degree range. If you drive a truck out of Colorado in mid January chances are you are going to see some weather, some of the trial sites were reporting unfrozen dosages so that data is very relevant.
So the good news is:
1) we have trial data from unaffected dosages and patient data to review
2) we have the previous SPRING data to use
3) we have recent unblinded data to review on the multiple injection patients
4) we have MRI data to review and the needle biopsy of synovial fluid
5) perhaps with the inclusion of all the data above, the BLA can be filed on time, this is the impression of management and I believe this also, plenty of data to review.
Why sell at these prices, in fact in the absence of any tangible bad data I'll buy more here.
We'll see the BLA filed on time using the multiple injection data and we will see the high resolution MRI data released shortly, Ampion works but it's hard to show this when the damn drug is frozen. Not the company's fault. Just delayed.
TH3, thanks and I did notice that lady dovsafir has a history of posting on this board or elsewhere that can be measured in hours not years.
So you are still trying to influence the board with your technical mumbo jumbo on a stock that can not yet be charted technically, it trades fundamentally and the pop on Monday related to news that was fundamental, so basically your continued attempts to be relevant here technically show your absurd ignorance. Do you even know what Ampion does?
You are a known short in support of another known short, your combined FUD is noticeable, in fact I have you on ignore imprvn, just came off ignore to give you some indication of my chart indicating a rising finger pattern in relation to your post. Your noise and smiley faces are really just ignored but now you don't understand this-- so whatever, take a look at the chart to the right and develop your forecast, steve would concur.
You are a known short in support of another known short, your combined FUD is noticeable, in fact I have you on ignore safety, just came off ignore to give you some indication of my chart indicating a rising finger pattern in relation to your post.
Yah, right......seriously---- every question you just asked is so basic makes me think you are still in high school, if so then ask your teacher, otherwise shorties unite on some other board, round here folks like me will heckle you guys big time.
Look at the chart to the right of AMPE
Like I said, everything you wrote above is meaningless and you now know you can not trade this stock technically-- at the moment-- later on, yes.
Any argument to the contrary would further prove your stupidity as a shortie making FUD all the time~ This is why nobody cares about your trades dude.
At this print it would still take ten days of this volume just for the shorts to cover, so all the volume at this point for the next ten days would be just shorts buying, that's remarkable and things are just beginning here.
While this is not the "official" news from STEP we are waiting for, this piece is nicely and strategically designed to slap the shorts in the face and provide some general guidance into the success of Ampion, allowing people to de-risk this trade and plan future purchases accordingly. This is a nice read.
So I see where others are getting the bigger picture, the stock is moving and has a few doubles in it before it's all done.
If the demand for shares to cover, is met with institutional demand, and demand from the average Joe, one morning, could be Monday, one morning there could be over 15 million shares traded within hours, where are all those shares going to come from? And at what price will they be offered? 15 million shares!
Where are these shorties going to find 6.4 million shares? Add to that an additional 6 million in demand from the institutional players, maybe 3 million in demand that morning from the average Joe and that means 15 million shares are purchased in just two or three hours but who would sell and at what price?